ATE367450T1 - Verfahren zur herstellung sequenzspezifischer proteasen durch gezielte evolution - Google Patents
Verfahren zur herstellung sequenzspezifischer proteasen durch gezielte evolutionInfo
- Publication number
- ATE367450T1 ATE367450T1 AT03727460T AT03727460T ATE367450T1 AT E367450 T1 ATE367450 T1 AT E367450T1 AT 03727460 T AT03727460 T AT 03727460T AT 03727460 T AT03727460 T AT 03727460T AT E367450 T1 ATE367450 T1 AT E367450T1
- Authority
- AT
- Austria
- Prior art keywords
- specific proteases
- proteases
- producing sequence
- targeted evolution
- sequence
- Prior art date
Links
- 102000035195 Peptidases Human genes 0.000 title abstract 4
- 108091005804 Peptidases Proteins 0.000 title abstract 4
- 239000004365 Protease Substances 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 abstract 3
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/58—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
- C12N9/60—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi from yeast
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1058—Directional evolution of libraries, e.g. evolution of libraries is achieved by mutagenesis and screening or selection of mixed population of organisms
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Ecology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Medicinal Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02010576A EP1361284A1 (de) | 2002-05-10 | 2002-05-10 | Verfahren zur Herstellung von sequenzspezifischen Proteasen durch zielgerichtete Evolution und deren Verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE367450T1 true ATE367450T1 (de) | 2007-08-15 |
Family
ID=29225644
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03727460T ATE367450T1 (de) | 2002-05-10 | 2003-05-09 | Verfahren zur herstellung sequenzspezifischer proteasen durch gezielte evolution |
Country Status (9)
| Country | Link |
|---|---|
| EP (2) | EP1361284A1 (de) |
| JP (1) | JP4448772B2 (de) |
| AT (1) | ATE367450T1 (de) |
| AU (2) | AU2003233314A1 (de) |
| CA (1) | CA2485452A1 (de) |
| DE (1) | DE60315014T2 (de) |
| DK (1) | DK1504117T3 (de) |
| ES (1) | ES2289288T3 (de) |
| WO (1) | WO2003095670A2 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7939304B2 (en) | 2002-10-02 | 2011-05-10 | Catalyst Biosciences, Inc. | Mutant MT-SP1 proteases with altered substrate specificity or activity |
| JP2006527590A (ja) | 2003-06-18 | 2006-12-07 | ディレボ・ビオテク・アーゲー | 新規生物学的実体およびその使用 |
| WO2005087947A2 (en) * | 2004-03-09 | 2005-09-22 | Meyer Pharmaceuticals Llc | Bioengineered proteolytic enzymes with enhanced specificity for cytokine receptors |
| DK1735439T3 (da) | 2004-04-12 | 2012-02-06 | Catalyst Biosciences Inc | Spaltning af VEGF og VEGF receptor ved hjælp af vild-type og mutant MT-SP1 |
| EP1827486A2 (de) * | 2004-12-22 | 2007-09-05 | Direvo Biotech AG | Gezielte verwendung von technisch manipulierten enzymen |
| EP2433642B1 (de) | 2005-10-21 | 2016-12-07 | Catalyst Biosciences, Inc. | Modifizierte Proteasen zur Hemmung der Komplementaktivierung |
| KR101778174B1 (ko) | 2006-07-05 | 2017-09-13 | 카탈리스트 바이오사이언시즈, 인코포레이티드 | 프로테아제 스크리닝 방법 및 이에 의해 확인된 프로테아제 |
| TWI465247B (zh) | 2008-04-11 | 2014-12-21 | Catalyst Biosciences Inc | 經修飾的因子vii多肽和其用途 |
| JPWO2012128260A1 (ja) | 2011-03-24 | 2014-07-24 | 旭硝子株式会社 | シゾサッカロミセス属酵母の形質転換体、該形質転換体の製造方法、β−グルコシダーゼの製造方法、およびセルロースの分解方法 |
| CN111019925B (zh) * | 2018-10-10 | 2022-08-23 | 上饶市康可得生物科技有限公司 | 筛选蛋白酶变体的方法以及获得的蛋白酶变体 |
| US12270124B2 (en) | 2018-10-10 | 2025-04-08 | Shangrao Concord Pharmaceutical Co., Ltd | Method for screening protease variant and obtained protease variant |
| WO2021030787A1 (en) | 2019-08-15 | 2021-02-18 | Catalyst Biosciences, Inc. | Modified factor vii polypeptides for subcutaneous administration and on-demand treatment |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9718591D0 (en) * | 1997-09-03 | 1997-11-05 | Zeneca Ltd | Methods |
| AU2001265092A1 (en) * | 2000-06-02 | 2001-12-17 | Regents Of The University Of California | Profiling of protease specificity using combinatorial fluorogenic substrate libraries |
-
2002
- 2002-05-10 EP EP02010576A patent/EP1361284A1/de not_active Withdrawn
-
2003
- 2003-05-09 AT AT03727460T patent/ATE367450T1/de active
- 2003-05-09 DK DK03727460T patent/DK1504117T3/da active
- 2003-05-09 JP JP2004503660A patent/JP4448772B2/ja not_active Expired - Fee Related
- 2003-05-09 AU AU2003233314A patent/AU2003233314A1/en not_active Abandoned
- 2003-05-09 DE DE60315014T patent/DE60315014T2/de not_active Expired - Lifetime
- 2003-05-09 WO PCT/EP2003/004864 patent/WO2003095670A2/en not_active Ceased
- 2003-05-09 CA CA002485452A patent/CA2485452A1/en not_active Abandoned
- 2003-05-09 ES ES03727460T patent/ES2289288T3/es not_active Expired - Lifetime
- 2003-05-09 EP EP03727460A patent/EP1504117B1/de not_active Expired - Lifetime
-
2009
- 2009-02-23 AU AU2009200749A patent/AU2009200749B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003233314A1 (en) | 2003-11-11 |
| JP4448772B2 (ja) | 2010-04-14 |
| AU2009200749A1 (en) | 2009-03-19 |
| DE60315014T2 (de) | 2008-04-10 |
| ES2289288T3 (es) | 2008-02-01 |
| WO2003095670A3 (en) | 2004-04-01 |
| EP1361284A1 (de) | 2003-11-12 |
| DK1504117T3 (da) | 2007-11-12 |
| CA2485452A1 (en) | 2003-11-20 |
| EP1504117A2 (de) | 2005-02-09 |
| JP2005525123A (ja) | 2005-08-25 |
| EP1504117B1 (de) | 2007-07-18 |
| AU2009200749B2 (en) | 2011-08-25 |
| DE60315014D1 (de) | 2007-08-30 |
| WO2003095670A2 (en) | 2003-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE374583T1 (de) | Herstellungsverfahren einer zahnärztlichen vorrichtung mit spritzguss | |
| DE60315014D1 (de) | Verfahren zur herstellung sequenzspezifischer proteasen durch gezielte evolution | |
| ATE445334T1 (de) | Verfahren zur herstellung von konzentratverdickungszusammensetzungen | |
| ATE338571T1 (de) | Verfahren zur oberflächenmodifizierung | |
| ATE410519T1 (de) | Verfahren zur herstellung einer wässrigen acrylamidlösung mit einem biokatalysator | |
| DE60238346D1 (de) | Verfahren zur herstellung von modifiziertem polymer, vorrichtung zur herstellung von modifiziertem polymer und modifiziertes polymer | |
| ATE352864T1 (de) | Verfahren zur herstellung von nanostrukturierten glühkörpern zur lichterzeugung | |
| ATE510024T1 (de) | Verfahren zur herstellung eines gepaarten tag aus einer nukleinsäuresequenz sowie verfahren zur verwendung davon | |
| ATE354282T1 (de) | Verfahren zur herstellung eines sojaproteinhydrolysates | |
| DE60236014D1 (de) | Verfahren zur herstellung von insulinverbindungen | |
| DE502004011342D1 (de) | Verfahren und vorrichtung zur herstellung eines bauteils, insbesondere eines hybridbaudteils für einen quertr ger eines fahrzeugs sowie bauteil und verwendung eines bauteils | |
| DE60221018D1 (de) | Verfahren und vorrichtung zur herstellung von kontaktlinsen | |
| DE60214555D1 (de) | Verfahren zur herstellung eines rohrkupplungsgreifrings und vorrichtung zur herstellung eines rohrkupplungsgreifrings | |
| DE10242955B4 (de) | Kunststoffaß und Verfahren zur Herstellung des Fasses | |
| ATE485381T1 (de) | Verfahren zur einführung eines gens in pflanzenmaterial | |
| DE50313574D1 (de) | Verfahren zur Keimreduktion von Abformmaterialien | |
| ATE306431T1 (de) | Verfahren zum herstellen eines kombi- verpackungsbehälters sowie vorrichtung zur durchführung des verfahrens | |
| DE50112449D1 (de) | Verfahren zur herstellung von 3,3-diarylpropylaminen | |
| ATE335855T1 (de) | Bakterien und verfahren zur herstellung von riboflavin durch fermentation | |
| ATE386027T1 (de) | Verfahren zur herstellung von valsartan | |
| DE602005024809D1 (de) | Verfahren zur herstellung von gabapentin | |
| ATE342873T1 (de) | Verfahren zur herstellung von lithiumamid | |
| ATE392413T1 (de) | Verfahren zur herstellung von beta-alaninamiden | |
| ATE525911T1 (de) | Verfahren zur verbesserung der fleischqualität von fisch,proteinhydrolysat und verfahren zur herstellung eines proteinhydrolysats | |
| DE602005002146D1 (de) | Verfahren zur mikrobiologischen Herstellung von optisch aktiven 3-Chlor-2-methyl-1,2-propandiol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1504117 Country of ref document: EP |
|
| EEIH | Change in the person of patent owner |